UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in HROW — Harrow, Inc.

CIK 861177 NEW YORK, NY

Back to HROW Full portfolio

Position in HROW

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,239,738

+$442,644 QoQ

Shares Held

52,737

+3.5% QoQ

Ownership

0.141%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#51

of 223 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 49% Shared 0% None 51%

Common Shares in HROW Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $852,377,607 across 33 Drug Manufacturers - Specialty & Generic names. HROW ranks #19 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	3,924,988	$282,049,632
2	TEVA	Teva Pharmaceutical Industries Ltd	3,832,465	$129,843,910
3	UTHR	UNITED THERAPEUTICS Corp	218,164	$118,207,795
4	NBIX	Neurocrine Biosciences Inc	504,233	$84,983,427
5	VTRS	Viatris Inc	4,293,757	$68,184,856
6	LNTH	Lantheus Holdings, Inc.	482,743	$53,555,505
7	ELAN	Elanco Animal Health Inc	1,510,327	$37,169,144
8	HIMS	Hims & Hers Health, Inc.	425,977	$14,768,619

All Filings in HROW

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,239,738	52,737	+3.5%	Shares	Defined	2026-08-13
2026-03-31	$1,797,094	50,967	-9.3%	Shares	Defined	2026-05-13
2025-12-31	$2,753,898	56,202	+4.2%	Shares	Defined	2026-02-13
2025-09-30	$2,598,586	53,935	-40.0%	Shares	Sole	2025-11-14
2025-06-30	$2,746,063	89,917	+40.2%	Shares	Defined	2025-08-14
2025-03-31	$1,706,149	64,141	+3.6%	Shares	Defined	2025-05-19
2024-12-31	$2,078,084	61,940	+89.5%	Shares	Defined	2025-02-14
2024-09-30	$1,469,202	32,678	—	Shares	Defined	2024-11-14
No filing history on record for this holder in this stock.